BRPI0915974A2 - métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero - Google Patents

métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero

Info

Publication number
BRPI0915974A2
BRPI0915974A2 BRPI0915974A BRPI0915974A BRPI0915974A2 BR PI0915974 A2 BRPI0915974 A2 BR PI0915974A2 BR PI0915974 A BRPI0915974 A BR PI0915974A BR PI0915974 A BRPI0915974 A BR PI0915974A BR PI0915974 A2 BRPI0915974 A2 BR PI0915974A2
Authority
BR
Brazil
Prior art keywords
mammal
expression
altering
disorder
alter
Prior art date
Application number
BRPI0915974A
Other languages
English (en)
Portuguese (pt)
Inventor
Friesen Kim
Zebulon Frantz Nolan
Michael Yamka Ryan
Gao Xiangming
Original Assignee
Hill´S Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hill´S Pet Nutrition Inc filed Critical Hill´S Pet Nutrition Inc
Publication of BRPI0915974A2 publication Critical patent/BRPI0915974A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0915974A 2008-07-18 2009-07-20 métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero BRPI0915974A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8218308P 2008-07-18 2008-07-18
PCT/US2009/051155 WO2010009468A1 (en) 2008-07-18 2009-07-20 Method for enhancing the quality of life of a senior animal

Publications (1)

Publication Number Publication Date
BRPI0915974A2 true BRPI0915974A2 (pt) 2017-05-30

Family

ID=41058652

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915974A BRPI0915974A2 (pt) 2008-07-18 2009-07-20 métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero

Country Status (10)

Country Link
US (1) US20110189303A1 (cg-RX-API-DMAC10.html)
EP (1) EP2320752A1 (cg-RX-API-DMAC10.html)
JP (2) JP2011528556A (cg-RX-API-DMAC10.html)
CN (1) CN102170792A (cg-RX-API-DMAC10.html)
AU (1) AU2009270712B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0915974A2 (cg-RX-API-DMAC10.html)
CA (1) CA2731088C (cg-RX-API-DMAC10.html)
RU (1) RU2525617C2 (cg-RX-API-DMAC10.html)
WO (1) WO2010009468A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201101281B (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
DK2367549T3 (da) * 2008-12-30 2013-11-04 Hills Pet Nutrition Inc Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr
RU2525579C2 (ru) * 2010-05-12 2014-08-20 Хилл`С Пет Ньютришн, Инк. Способы контроля и профилактики воспаления и ослабления воспалительных состояний у животных компаньонов
US20130059028A1 (en) * 2011-09-01 2013-03-07 Julie Marie Foy Compositions and Methods for Providing a Life-Stage-Appropriate Animal Diet
AU2012355775B2 (en) 2011-12-19 2015-10-08 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
CA2916639C (en) * 2013-07-01 2020-10-13 Washington University Human diet equivalent animal feed
EP2898769A1 (en) * 2014-01-23 2015-07-29 Beefeaters Holding Company, Inc. Dental care product for pets
JP6848962B2 (ja) * 2016-03-16 2021-03-24 味の素株式会社 行動体力向上剤
EP3466428A1 (de) * 2017-10-09 2019-04-10 Phytobiotics Futterzusatzstoffe GmbH Tiernahrung mit febrifugin zur leistungssteigerung
US20250032423A1 (en) * 2023-07-25 2025-01-30 Edhas Technologies Inc. Herbal bioactives based immunostimulant formulation for poultry birds & cattle and preparation thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1149710A (en) * 1913-11-28 1915-08-10 Michael Beck Heavy-oil carbureter for explosive-engines.
US2988045A (en) * 1959-12-28 1961-06-13 Stanton E Fisher Animal toy
US3104648A (en) * 1962-02-26 1963-09-24 Stanton E Fisher Animal toy
US3202514A (en) * 1963-07-15 1965-08-24 Gen Foods Corp Animal food and method of making the same
US3441001A (en) * 1967-05-19 1969-04-29 Ring Sidney B Corrugated animal toy
US3871334A (en) * 1973-12-03 1975-03-18 Herbert R Axelrod Pet toy
JPS56106593A (en) * 1980-01-24 1981-08-24 Dainippon Pharmaceut Co Ltd Alkali protease m3
US5004624A (en) * 1983-03-14 1991-04-02 Star-Kist Foods, Inc. Semi-moist pet food having free gravy and process for preparation thereof
US4513014A (en) * 1983-10-11 1985-04-23 Edwards Philip L Chewable toy for animal
US4557219A (en) * 1983-10-11 1985-12-10 Edwards Philip L Chewable toy for animal
US4674444A (en) * 1985-07-01 1987-06-23 Axelrod Herbert R Chewing toy for dogs and preparation thereof
US4771733A (en) * 1986-09-17 1988-09-20 Axelrod Herbert R Chewable object having flavor or odor extract incorporated therein
US4997672A (en) * 1987-03-10 1991-03-05 Virginia Commonwealth University Salt taste enhancer
US4997671A (en) * 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US4928632A (en) * 1988-09-13 1990-05-29 Gordon Richard A Cat toy
US5114704A (en) * 1989-05-30 1992-05-19 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
JPH05339154A (ja) * 1992-06-03 1993-12-21 Sagami Chem Res Center 肝機能改善剤
US5419283A (en) * 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5532010A (en) * 1993-05-28 1996-07-02 Nabisco, Inc. Coated canine biscuits and preparation process
US5339771A (en) * 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
JPH10248424A (ja) * 1997-03-05 1998-09-22 Sakai Pet Sangyo:Kk 愛玩動物用飼育装置及びそれに使用する飼育用部材
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
ATE512594T1 (de) * 1999-09-09 2011-07-15 Nestle Sa Verbesserung des zustandes älterer haustiere
JP2001169731A (ja) * 1999-12-17 2001-06-26 Showa Denko Kk 動物体の脂質代謝改善剤
US6379727B1 (en) * 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
EP1250052A1 (en) * 2000-01-25 2002-10-23 Juvenon, Inc. Nutritional supplements for aged pets
US20020115710A1 (en) * 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US20040176451A1 (en) * 2001-06-18 2004-09-09 Tadakazu Tamai Pparg agonistic medicinal compositions
ATE548441T1 (de) * 2001-10-18 2012-03-15 Council Scient Ind Res Cholesterin senkende strukturierte lipide mit omega 3 pufa
EP1350435B1 (en) * 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
JP2007524402A (ja) * 2003-07-03 2007-08-30 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法
ES2525729T3 (es) * 2003-11-25 2014-12-29 Virginia Tech Intellectual Properties, Inc. Composición para consumo animal para su uso en la reducción de la actividad MAP cinasa
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
JP4702678B2 (ja) * 2004-06-07 2011-06-15 環境創研株式会社 競走馬用飼料添加材
GB0413730D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
US20060002985A1 (en) * 2004-07-02 2006-01-05 Zicker Steven C Compositions and methods for decreasing age-related deterioration in mental activities in companion animals
JP4317801B2 (ja) * 2004-08-10 2009-08-19 学校法人武庫川学院 脂質代謝改善用の食品組成物およびこれを含有する食品
JP5543688B2 (ja) * 2004-08-30 2014-07-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ゲノムベースのダイエットデザイン
WO2006053010A2 (en) * 2004-11-09 2006-05-18 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
ES2550952T3 (es) * 2004-11-24 2015-11-13 Hill's Pet Nutrition, Inc. Composición para su uso en la mejora del aclaramiento hepático de sustancias xenobióticas en un animal
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
MX2007011031A (es) * 2005-03-08 2008-04-21 Reliant Pharmaceuticals Inc Tratamiento con estatina y acidos grasos omega-3 y un producto de combinacion de los mismos.
CN101247833B (zh) * 2005-06-29 2013-02-13 希尔氏宠物营养品公司 预防和治疗炎性疾病的方法和组合物
JP5590758B2 (ja) * 2005-08-03 2014-09-17 太陽化学株式会社 マーカータンパク質量調節用組成物
CA2627498C (en) * 2005-11-10 2013-06-11 Hill's Pet Nutrition, Inc. Compositions and methods for improving skin health and pelage quality
RU2450815C2 (ru) * 2005-12-16 2012-05-20 Н.В. Нютрисиа Применение растворимых пищевых волокон против мышечной атрофии
WO2007088046A2 (en) * 2006-02-01 2007-08-09 Nestec S.A. Nutritional system and methods for increasing longevity
JP2009528028A (ja) * 2006-02-24 2009-08-06 ディーエスエム アイピー アセッツ ビー．ブイ． 哺乳類における健康状態を促進するためのレスベラトロールおよびその誘導体の使用
US8067152B2 (en) * 2006-02-27 2011-11-29 The Fred Hutchinson Cancer Research Center Liver cancer biomarkers
CA2660291C (en) * 2006-08-09 2011-11-22 The Iams Company Methods of improving bone health and muscle health
CA2709660C (en) * 2008-01-04 2018-06-05 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions

Also Published As

Publication number Publication date
CN102170792A (zh) 2011-08-31
ZA201101281B (en) 2014-07-30
AU2009270712B2 (en) 2013-02-21
CA2731088C (en) 2015-09-22
JP2011528556A (ja) 2011-11-24
US20110189303A1 (en) 2011-08-04
CA2731088A1 (en) 2010-01-21
AU2009270712A1 (en) 2010-01-21
WO2010009468A1 (en) 2010-01-21
EP2320752A1 (en) 2011-05-18
JP2015091246A (ja) 2015-05-14
RU2011105794A (ru) 2012-08-27
RU2525617C2 (ru) 2014-08-20

Similar Documents

Publication Publication Date Title
BRPI0916576A2 (pt) pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio.
BRPI0717633A2 (pt) Anticorpo, composição farmacêutica, e, métodos para detectar uma célula expressando cxcr7 em uma amostra biológica, para tratar, prevenir ou melhorar uma doença e para identificar um modulador de cxcr7
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0815318A2 (pt) "método e sistema para avaliação de uma condição de um componente".
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
HUE060029T2 (hu) Emberi antitestek, amelyek kötnek limfocita aktivációs gént-3 (LAG-3) és azok felhasználásai
EA200900767A1 (ru) Антагонистические антитела против ephb3
BRPI0812770A2 (pt) Método in vitro para identificar uma pluralidade de moléculas antigênicas transportadas por eritrócitos de um indivíduo, e/ou identificar uma pluralidade de anticorpos contra moléculas antigênicas transportadas por eritrócitos, conjunto de reagentes para implementar o método de detecção .
BRPI0915382A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou um distúrbio.
BRPI0817693A2 (pt) Métodos e aparelho para iluminar ovos atráves de detecção de batimento cardíaco do embrião
CU20120095A7 (es) Antagonistas de pcsk9
WO2008115518A3 (en) Biomarkers of sirtuin activity and methods of use thereof
BRPI0818244A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratamento de um distúrbio ou doença
BR112014017626A2 (pt) métodos para tratar uma doença ou disfunção, métodos de identificação de um indivíduo, método para prever se um indivíduo com uma doença ou disfunção tem mais ou menos probabilidade para desenvolver toxicidade ao tratamento, método para determinar se um indivíduo com uma doença ou disfunção deve continuar ou suspender o tratamento que compreende um modulador de fgf19, método de otimização de eficácia terapêutica e método de ensaio
BRPI0813216A2 (pt) Inibidores de proteínas cinases e métodos para usá-los.
BR112012007365A2 (pt) proteínas de ligação à il-1
BRPI0921805A2 (pt) anticorpos que especificamente bloqueiam a atividade biológica de um antígeno de tumor
BRPI0815591A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
WO2007044695A3 (en) ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF
WO2012094580A3 (en) Compounds that modulate oxidative stress
BRPI0813456A2 (pt) Composto, uso do mesmo, composição farmacêutica, e, métodos para tratar um mamífero sofrendo de um distúrbio e de uma doença
WO2007114986A3 (en) Cooperative probes and methods of using them
EP2133342A4 (en) INHIBITOR OF PROTEINTHYROSINE PHOSPHATASE 1B, METHOD OF MANUFACTURE AND APPLICATIONS THEREOF
BR112012002001A2 (pt) método para tratar uma doença e/ou distúrbio do olho, formulação farmacêutica, e, kit
BRPI1016065A2 (pt) "processo para detectar, de maneira quantitativa, uma proteína alvo em uma amostra."

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B15K Others concerning applications: alteration of classification

Ipc: A23K 50/40 (2016.01), A23K 20/147 (2016.01), A23K

B11T Dismissal of application maintained [chapter 11.20 patent gazette]